Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Weight in Type 2 Diabetes Mellitus and Therapeutic Regimen Recommendation.

Dong-Dong Wang Yi-Zhen Mao Yang Yang Tian-Yun Wang Ping Zhu Su-Mei He Xiao Chen

Published in: Journal of diabetes research (2022)

This was the first study to explore effects of SGLT-2 inhibitors on weight in T2DM; meanwhile, the optimum dosages and treatment durations on weight from canagliflozin, empagliflozin, ertugliflozin, ipragliflozin, luseogliflozin, and tofogliflozin were recommended, respectively.

Keyphrases

body mass index
weight loss
physical activity
weight gain
body weight
metabolic syndrome
combination therapy
glycemic control